| scholarly article | Q13442814 |
| P50 | author | Seyed Moayed Alavian | Q28321890 |
| P2093 | author name string | Leila Mehrnoush | |
| Shima Salimi | |||
| Nasser Ebrahimi Daryani | |||
| Hossein Farzi | |||
| P2860 | cites work | Body mass index is a stronger predictor of alanine aminotransaminase levels than alcohol consumption | Q46537178 |
| The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. | Q46888777 | ||
| Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study | Q46959082 | ||
| Predicting cirrhosis risk based on the level of circulating hepatitis B viral load | Q46985831 | ||
| Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. | Q51465087 | ||
| Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B | Q57935382 | ||
| Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma | Q84441185 | ||
| Drug-induced liver injury | Q87031912 | ||
| Hepatitis B virus: inactive carriers | Q24810833 | ||
| EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Preliminary report of hepatitis B virus genotype prevalence in Iran | Q33868660 | ||
| Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. | Q34007571 | ||
| Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis | Q34157099 | ||
| Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients | Q34462246 | ||
| Assessment of noninvasive liver stiffness in inactive HBsAg carriers by transient elastography: Fibroscan in inactive HBsAg carriers. | Q35507606 | ||
| Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010. | Q36177134 | ||
| Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up | Q37180029 | ||
| Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes | Q37261934 | ||
| Spontaneous relapse of hepatitis in inactive HBsAg carriers | Q37278056 | ||
| Practical guidelines for diagnosis and early management of drug-induced liver injury | Q37341906 | ||
| Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. | Q37347303 | ||
| Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review | Q37997294 | ||
| Natural history of chronic hepatitis B: what exactly has REVEAL revealed? | Q38003214 | ||
| Assessment of hepatic fibrosis and necroinflammation among inactive HBsAg carriers in Egypt. | Q39000509 | ||
| The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community | Q39896653 | ||
| High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. | Q42166128 | ||
| Risk factors for serum alanine aminotransferase elevation: A cross-sectional study of healthy adult males in Tokyo, Japan | Q43067235 | ||
| Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death | Q43180169 | ||
| An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers. | Q43285528 | ||
| Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers | Q43954106 | ||
| The prevalence and etiology of elevated aminotransferase levels in the United States | Q44480010 | ||
| What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis? | Q44501214 | ||
| Hepatitis B inactive carriers: clinical course and outcomes | Q45292056 | ||
| Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | Q45355080 | ||
| Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus | Q45384368 | ||
| Hepatitis B virus genotype A is more often associated with severe liver disease in northern India than is genotype D. | Q45495100 | ||
| Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time | Q46045006 | ||
| Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town | Q46446542 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | L-alanine | Q218642 |
| P304 | page(s) | e17537 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Hepatitis Monthly | Q15734417 |
| P1476 | title | Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection | |
| P478 | volume | 14 |
| Q59359167 | Acute hepatitis E superinfection leading to chronic hepatitis B reactivation |
| Q30251618 | Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis |
| Q91209053 | Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses |
Search more.